Your browser is no longer supported. Please, upgrade your browser.
Settings
CHRS Coherus BioSciences, Inc. daily Stock Chart
CHRS [NASD]
Coherus BioSciences, Inc.
Index- P/E- EPS (ttm)-3.13 Insider Own0.10% Shs Outstand67.09M Perf Week11.32%
Market Cap817.83M Forward P/E- EPS next Y-1.27 Insider Trans-36.04% Shs Float62.58M Perf Month22.14%
Income-195.80M PEG- EPS next Q-0.86 Inst Own96.00% Short Float12.75% Perf Quarter-8.55%
Sales0.00M P/S- EPS this Y-47.50% Inst Trans0.38% Short Ratio10.07 Perf Half Y-17.91%
Book/sh0.18 P/B67.72 EPS next Y59.30% ROA-126.20% Target Price27.00 Perf Year-10.37%
Cash/sh1.75 P/C6.98 EPS next 5Y23.00% ROE-741.70% 52W Range8.32 - 20.66 Perf YTD34.70%
Dividend- P/FCF- EPS past 5Y-34.20% ROI-174.00% 52W High-41.00% Beta3.52
Dividend %- Quick Ratio5.30 Sales past 5Y-3.90% Gross Margin- 52W Low46.51% ATR0.74
Employees182 Current Ratio5.30 Sales Q/Q- Oper. Margin- RSI (14)67.14 Volatility5.96% 7.84%
OptionableYes Debt/Eq8.28 EPS Q/Q20.60% Profit Margin- Rel Volume1.28 Prev Close12.34
ShortableYes LT Debt/Eq8.28 EarningsFeb 07 AMC Payout- Avg Volume792.26K Price12.19
Recom1.60 SMA2023.78% SMA5014.52% SMA200-15.01% Volume1,017,612 Change-1.22%
Aug-28-18Initiated H.C. Wainwright Buy $28
Mar-09-18Reiterated Maxim Group Buy $20 → $15
Aug-08-17Reiterated JP Morgan Overweight $32 → $25
Jun-13-17Reiterated Maxim Group Buy $44 → $40
May-05-17Initiated BMO Capital Markets Outperform $54
Oct-19-16Initiated Robert W. Baird Outperform $40
Sep-07-16Initiated Maxim Group Buy $43
Jul-27-16Initiated Citigroup Buy $36
Jan-20-16Initiated Credit Suisse Outperform
Jan-15-19 11:03AM  Coherus BioSciences, Inc. (NASDAQ:CHRS) Is Expected To Breakeven Simply Wall St.
Jan-14-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-07-19 09:25AM  Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners GlobeNewswire +18.22%
Jan-02-19 09:30AM  Coherus BioSciences Management to Present at The 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-18 10:53AM  Edited Transcript of CHRS earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -7.98%
Dec-19-18 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Dec-13-18 01:36AM  Edited Transcript of CHRS earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
Dec-12-18 12:13AM  Should You Buy Coherus Biosciences Inc (CHRS)? Insider Monkey
Dec-03-18 07:40AM  Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences Discovering Underlying Factors of Influence GlobeNewswire
Nov-30-18 09:30AM  Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS GlobeNewswire
Nov-29-18 07:52AM  Coherus BioSciences (CHRS): Moving Average Crossover Alert Zacks
Nov-27-18 06:00PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire -5.79%
Nov-16-18 10:20AM  Is Coherus BioSciences Incs (NASDAQ:CHRS) CEO Paid Enough Relative To Peers? Simply Wall St.
Nov-12-18 08:00AM  Coherus BioSciences Management to Present at the 27th Annual Credit Suisse Healthcare Conference GlobeNewswire +8.85%
Nov-08-18 05:03PM  Coherus prices biosimilar to Amgen's Neulasta at 33 pct discount Reuters
05:02PM  Coherus BioSciences: 3Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and Third Quarter 2018 Financial Results GlobeNewswire
Nov-02-18 01:41PM  U.S. FDA Approves UDENYCA (pegfilgrastim-cbqv) GlobeNewswire +6.03%
Oct-24-18 09:15AM  New Research: Key Drivers of Growth for UnitedHealth Group, The Wendy's Co., Xenia Hotels & Resorts, TopBuild, Coherus BioSciences, and Virtu Financial Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire -10.09%
Oct-22-18 08:00AM  Coherus BioSciences to Report Third Quarter 2018 Financial Results on November 8th GlobeNewswire
Oct-11-18 03:02PM  Here's Why Coherus BioSciences Fell 18.1% in September Motley Fool
Oct-09-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-26-18 12:32PM  Amgen's Neulasta Has a New Competitor in Europe GuruFocus.com
Sep-25-18 01:38PM  Coherus BioSciences Receives European Commission Approval for UDENYCA (Pegfilgrastim Biosimilar) GlobeNewswire
Sep-21-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-17-18 08:00AM  Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October GlobeNewswire
Sep-12-18 12:27PM  Edited Transcript of CHRS earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-31-18 07:50AM  Research Report Identifies Holly Energy Partners, First Merchants, Enbridge Energy Management, Activision Blizzard, Coherus BioSciences, and Kala Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-20-18 08:00AM  Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September GlobeNewswire
Aug-17-18 05:30PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Aug-08-18 06:14PM  Coherus BioSciences: 2Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-27-18 09:36AM  Coherus BioSciences Receives Positive CHMP Opinion for UDENYCA (Pegfilgrastim Biosimilar Candidate) GlobeNewswire
08:20AM  Market Trends Toward New Normal in United Technologies, Paychex, Coherus BioSciences, InfraREIT, Cousins Properties, and Engility Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-25-18 04:05PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jul-24-18 08:00AM  Coherus BioSciences to Report Second Quarter 2018 Financial Results on August 8th GlobeNewswire
Jul-18-18 12:14PM  Here's Why Coherus Biosciences Rose Over 21% Today Motley Fool +20.13%
Jul-06-18 07:20AM  Free Technical Research on Clovis Oncology and Three More Biotech Equities ACCESSWIRE
Jun-26-18 08:40AM  Implied Volatility Surging for Coherus BioSciences (CHRS) Stock Options Zacks
Jun-22-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +5.52%
May-25-18 09:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
May-22-18 07:38PM  Coherus Prices Public Offering of Common Stock GlobeNewswire
May-21-18 04:15PM  Coherus Announces Proposed Public Offering of Common Stock GlobeNewswire
May-17-18 07:10AM  Blog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat Conference ACCESSWIRE
May-14-18 12:39PM  U.S. Food and Drug Administration Accepts and Acknowledges Coherus BioSciences Biologics License Application of CHS-1701 (Pegfilgrastim Biosimilar Candidate) for Review GlobeNewswire
May-10-18 05:14PM  Coherus BioSciences: 1Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and First Quarter 2018 Financial Results GlobeNewswire
09:00AM  Coherus BioSciences Appoints Samuel Nussbaum, M.D. to Board of Directors GlobeNewswire
May-03-18 09:16AM  Coherus BioSciences Re-Submits Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate) GlobeNewswire +17.32%
May-01-18 09:00AM  Coherus BioSciences Management to Present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada GlobeNewswire
Apr-24-18 09:00AM  Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10th GlobeNewswire
Apr-19-18 04:45PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Apr-02-18 09:00AM  Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco GlobeNewswire -7.24%
Mar-16-18 07:00AM  Free Post Earnings Research Report: Cambrex Achieved Record Quarterly Revenue; EPS Climbed 4% ACCESSWIRE
Mar-13-18 04:15PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Mar-09-18 04:33PM  Why II-VI, Coherus Biosciences, and El Pollo Loco Holdings Jumped Today Motley Fool +30.22%
04:20PM  How This Small-Cap Biotech Plans To Chip Away At Amgen's Biggest Drugs Investor's Business Daily
04:06PM  Edited Transcript of CHRS earnings conference call or presentation 8-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
11:49AM  Why Coherus Biosciences Is Skyrocketing Today Motley Fool
05:03AM  Coherus BioSciences reports 4Q loss Associated Press
Mar-08-18 04:00PM  Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
01:15PM  Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-18 09:00AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March GlobeNewswire
Feb-27-18 09:00AM  Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th GlobeNewswire
Feb-23-18 08:00AM  Report: Developing Opportunities within Tupperware Brands, Eaton Vance, Marcus & Millichap, Lockheed Martin, Coherus BioSciences, and Capricor Therapeutics Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-05-18 08:00AM  AbSci Appoints Alan Herman, PhD to Scientific Advisory Board PR Newswire
Jan-17-18 06:10AM  Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18) TheStreet.com
Jan-16-18 07:36PM  Winners & losers from JP Morgan Healthcare Conference CNBC Videos -7.35%
06:59PM  Cramer reveals the biggest winners and losers from the JP... CNBC Videos
Jan-15-18 03:45PM  From drug pricing and 'biosimilars' to opioids and culture a wrap and podcast from biotech's big conference American City Business Journals
Jan-11-18 08:00AM  Here's What AbbVie's Management Just Said About Its Future Motley Fool +11.38%
Jan-09-18 08:05AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Jan-02-18 09:00AM  Coherus BioSciences Management to Present at The 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire +8.52%
08:04AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Dec-27-17 11:05AM  ETFs with exposure to Coherus BioSciences, Inc. : December 27, 2017 Capital Cube
Dec-08-17 08:04AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit +7.10%
Dec-01-17 09:00AM  Coherus BioSciences Management to Present at BMOs Prescriptions for Success Healthcare Conference GlobeNewswire
Nov-30-17 08:04AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Nov-17-17 09:12AM  Trade of the Day: Coherus Biosciences Inc (CHRS) InvestorPlace -11.64%
Nov-15-17 08:07AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Nov-08-17 06:41PM  Edited Transcript of CHRS earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-06-17 04:35PM  Coherus BioSciences reports 3Q loss Associated Press
04:00PM  Coherus BioSciences Reports Third Quarter 2017 Operating and Financial Results GlobeNewswire
Nov-01-17 09:00AM  Coherus BioSciences Management to Present at Credit Suisse Scottsdale Healthcare Conference GlobeNewswire
Oct-24-17 08:14AM  Coherus BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : CHRS-US : October 24, 2017 Capital Cube
Oct-23-17 08:30AM  Coherus BioSciences to Report Third Quarter 2017 Financial Results on November 6th GlobeNewswire
Oct-20-17 10:08AM  ETFs with exposure to Coherus BioSciences, Inc. : October 20, 2017 Capital Cube
Oct-09-17 11:24AM  ETFs with exposure to Coherus BioSciences, Inc. : October 9, 2017 Capital Cube
08:02AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Oct-06-17 09:06AM  Coherus BioSciences, Inc. :CHRS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-25-17 09:29AM  UBS Downgrades AbbVie; Here's What Changed Analysts' View Benzinga +5.06%
Sep-11-17 09:02PM  3 Stocks With McDonald's-Like Return Potential Motley Fool
10:41AM  Coherus BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : CHRS-US : September 11, 2017 Capital Cube
Sep-07-17 07:30PM  AbbVie Scores 2 Wins: 1 Threatens Regeneron Motley Fool -6.25%
11:57AM  Coherus BioSciences Provides Update on 619 IPR Institution Decision GlobeNewswire
Sep-01-17 09:00AM  Coherus BioSciences Management to Present at Three Investor Healthcare Conferences in September GlobeNewswire
Aug-29-17 09:47PM  Coherus BioSciences, Inc. Value Analysis (NASDAQ:CHRS) : August 30, 2017 Capital Cube
Aug-28-17 08:30AM  Coherus BioSciences Announces Positive Topline Results for Clinical Pharmacokinetic Bioequivalence Study for CHS-1420 (Humira® Biosimilar Candidate) versus European Marketed Humira in Healthy Subjects GlobeNewswire
Aug-25-17 08:03AM  See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Coherus BioSciences, Inc., a biosimilar company, develops and commercializes various therapeutic products worldwide. The company engages in the development of late-stage clinical products, including CHS-1701 pegfilgrastim biosimilar, a granulocyte colony-stimulating factor product candidate; CHS-1420 adalimumab biosimilar, an anti-tumor necrosis factor product candidate; and CHS-0214, an etanercept biosimilar for rheumatoid arthritis and psoriasis. It is also developing a pipeline of products in therapeutic areas, such as oncology, immunology, and ophthalmology comprising CHS-3351, a ranibizumab biosimilar; and CHS-2020, an aflibercept biosimilar, as well as CHS-131, a small molecule for multiple sclerosis. Coherus BioSciences, Inc. has license agreement with Selexis SA and Genentech, Inc. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Viret Jean-FredericChief Financial OfficerSep 21Option Exercise13.507409,9904,519Sep 25 04:05 PM
FINCK BARBARA KChief Medical OfficerSep 10Option Exercise1.421,7602,49938,803Sep 12 04:05 PM
FINCK BARBARA KChief Medical OfficerSep 10Sale18.581,76032,69937,043Sep 12 04:05 PM
HEALY JAMESDirectorAug 29Sale20.5025,000512,5002,868,221Aug 31 05:23 PM
FINCK BARBARA KChief Medical OfficerAug 13Option Exercise1.421,7602,49938,803Aug 15 04:05 PM
FINCK BARBARA KChief Medical OfficerAug 13Sale19.021,76033,48037,043Aug 15 04:05 PM
Viret Jean-FredericChief Financial OfficerJul 23Sale18.569,291172,4723,779Jul 25 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 10Option Exercise1.421,2601,78938,303Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 10Sale15.001,26018,90037,043Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 09Option Exercise1.4250071037,543Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 09Sale15.035007,51537,043Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJun 18Option Exercise1.421,7602,49938,803Jun 20 04:09 PM
FINCK BARBARA KChief Medical OfficerJun 18Sale15.001,76026,40037,043Jun 20 04:09 PM
Lanfear Dennis MSee RemarksMay 16Sale16.2620,984341,2651,316,582May 17 05:59 PM